Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Sacroiliac Joint Related Low Back Pain

NCT05396495 is registered in ClinicalTrials.gov with FUSMobile Inc. as lead sponsor.

NCT NCT05396495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05396495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Sacroiliac Joint Related Low Back Pain
Lead sponsor
FUSMobile Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
October 24, 2022
Completion date
December 1, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sacroiliitis